Similar Articles
301 Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study
302 Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression via E2F transcription factor 1/G protein subunit alpha Z axis
303 Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma
304 Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
305 Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling
306 Real-world clinical effectiveness of sorafenib among patients with unresectable hepatocellular carcinoma at two centers in the United States
307 Preoperative prediction of microvascular invasion in hepatocellular carcinoma using ultrasound features including elasticity
308 Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
309 Prognostic model of hepatocellular carcinoma based on cancer grade
310 Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA